Cite
Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis.
MLA
Liu, Ruolin, et al. “Risk of Non-Melanoma Skin Cancer with Biological Therapy in Common Inflammatory Diseases: A Systemic Review and Meta-Analysis.” Cancer Cell International, vol. 21, no. 1, Nov. 2021, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12935-021-02325-9.
APA
Liu, R., Wan, Q., Zhao, R., Xiao, H., Cen, Y., & Xu, X. (2021). Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis. Cancer Cell International, 21(1), 1–17. https://doi.org/10.1186/s12935-021-02325-9
Chicago
Liu, Ruolin, Qianyi Wan, Rui Zhao, Haitao Xiao, Ying Cen, and Xuewen Xu. 2021. “Risk of Non-Melanoma Skin Cancer with Biological Therapy in Common Inflammatory Diseases: A Systemic Review and Meta-Analysis.” Cancer Cell International 21 (1): 1–17. doi:10.1186/s12935-021-02325-9.